Home
About Us
Covid-19
NRX-100/101
News
Contact
Home
News
Broadcasts
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Broadcasts
June 15, 2020
August 5, 2020
Related Posts
Press releases
November 13, 2020
November 13, 2020
NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure
Read more
News
August 5, 2020
August 6, 2020
Which COVID-19 treatments are showing promise? A list of potential drugs
Read more
Press releases
November 5, 2020
November 5, 2020
NeuroRx and Relief Therapeutics announce continuation of RLF-100™ trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020
Read more
